NCT03899246View on ClinicalTrials.gov

Sickle Cell Pain: Intervention With Capsaicin Exposure

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 3, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

March 30, 2020

Conditions
Neuropathic PainSickle Cell Disease
Interventions
DRUG

Eight Percent Topical Capsaicin

See arm description

Trial Locations (1)

48201

Children's Hospital of Michigan, Detroit

All Listed Sponsors
lead

Children's Hospital of Michigan

OTHER

NCT03899246 - Sickle Cell Pain: Intervention With Capsaicin Exposure | Biotech Hunter | Biotech Hunter